Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Pavmed Inc (PAVM)

Pavmed Inc (PAVM)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 493,988
  • Shares Outstanding, K 83,869
  • Annual Sales, $ 0 K
  • Annual Income, $ -34,280 K
  • 60-Month Beta 0.29
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 10.74
Trade PAVM with:

Options Overview

Details
  • Implied Volatility 90.45%
  • Historical Volatility 54.37%
  • IV Percentile 7%
  • IV Rank 4.20%
  • IV High 259.18% on 03/03/21
  • IV Low 83.05% on 05/26/21
  • Put/Call Vol Ratio 0.16
  • Today's Volume 1,226
  • Volume Avg (30-Day) 1,733
  • Put/Call OI Ratio 0.33
  • Today's Open Interest 24,779
  • Open Int (30-Day) 23,437

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.09
  • Growth Rate Est. (year over year) +1,110,100.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.83 +52.22%
on 05/17/21
6.57 -11.20%
on 06/08/21
+1.80 (+44.67%)
since 05/14/21
3-Month
3.81 +53.02%
on 05/13/21
6.59 -11.53%
on 04/07/21
+1.49 (+34.33%)
since 03/12/21
52-Week
1.63 +257.67%
on 12/18/20
6.59 -11.53%
on 04/07/21
+3.89 (+200.52%)
since 06/12/20

Most Recent Stories

More News
Tim Baxter, Former CEO of Samsung Electronics North America and Global Technology Industry Leader, Joins PAVmed Board of Directors

PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the "Company" or "PAVmed"), a highly differentiated, multi-product, commercial-stage medical technology company, today announced the appointment of prominent global technology...

PAVM : 5.83 (-1.02%)
PAVMZ : 4.25 (+0.71%)
Medrio Selected as Exclusive Data Management Solution for Leading Device and Diagnostic Sponsor

/PRNewswire-PRWeb/ -- Medrio, Inc., a leading provider of decentralized and eClinical technology to pharmaceutical, biotech, medical device, diagnostics, and animal health markets, has been selected as...

PAVM : 5.83 (-1.02%)
PAVmed Subsidiary Lucid Diagnostics Completes European CE Mark Certification of its EsoGuard Esophageal DNA Test

PAVmed Inc. (Nasdaq: PAVM, PAVMZ) ("PAVmed"), a highly differentiated, multi-product, commercial-stage medical device company, today announced that its major subsidiary, Lucid Diagnostics Inc. ("Lucid"),...

PAVM : 5.83 (-1.02%)
PAVMZ : 4.25 (+0.71%)
PAVmed Launches Digital Health Company Veris Health Inc.

New subsidiary Veris acquires privately held oncology digital health company Oncodisc Inc.

PAVM : 5.83 (-1.02%)
PAVMZ : 4.25 (+0.71%)
BDX : 242.72 (+0.03%)
PAVmed Subsidiary Lucid Diagnostics Receives CE Mark Certification for its EsoCheck(R) Esophageal Cell Collection Device

PAVmed Inc. (Nasdaq: PAVM, PAVMZ) ("PAVmed"), a highly differentiated, multi-product, commercial-stage medical device company, and its major subsidiary Lucid Diagnostics Inc. ("Lucid"), today announced...

PAVM : 5.83 (-1.02%)
PAVMZ : 4.25 (+0.71%)
PAVmed Receives European CE Mark Certification for its CarpX(R) Minimally Invasive Carpal Tunnel Device

PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the "Company" or "PAVmed"), a highly differentiated, multi-product, commercial-stage medical device company, today announced that it has received CE Mark certification...

PAVM : 5.83 (-1.02%)
PAVMZ : 4.25 (+0.71%)
Data Presented at Digestive Disease Week 2021 Support Clinical Utility of PAVmed Subsidiary Lucid Diagnostics' EsoCheck and EsoGuard Technologies

Initial NYU experience in 99 patients demonstrated EsoCheck and EsoGuard capable of detecting esophageal precancer in chronic heartburn patients

PAVM : 5.83 (-1.02%)
PAVMZ : 4.25 (+0.71%)
PAVmed Provides Business Update and First Quarter 2021 Financial Results

Conference call to be held today at 4:30 PM EDT

PAVM : 5.83 (-1.02%)
PAVMZ : 4.25 (+0.71%)
PAVmed, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / May 17, 2021 / PAVmed, Inc. (NASDAQ:PAVM) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on May 17, 2021 at 4:30 PM Eastern Time....

PAVM : 5.83 (-1.02%)
PAVmed Subsidiary Lucid Diagnostics Announces Upcoming Presentation at Digestive Disease Week 2021

Dr. David Poppers to present on his initial experience with Lucid's EsoCheck and EsoGuard

PAVM : 5.83 (-1.02%)
PAVMZ : 4.25 (+0.71%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

PAVmed Inc. is a medical device company. Its diversified pipeline of products address unmet clinical needs, which consists of CarpX (TM) to treat carpal tunnel syndrome; NextFlo(TM) and NextCath(TM) a disposable infusion pump; PortIO(TM) and NextCath interventional radiology and Caldus (TM) tissue ablation...

See More

Key Turning Points

3rd Resistance Point 6.11
2nd Resistance Point 6.00
1st Resistance Point 5.92
Last Price 5.83
1st Support Level 5.73
2nd Support Level 5.62
3rd Support Level 5.54

See More

52-Week High 6.59
Last Price 5.83
Fibonacci 61.8% 4.70
Fibonacci 50% 4.11
Fibonacci 38.2% 3.52
52-Week Low 1.63

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar